scholarly article | Q13442814 |
P356 | DOI | 10.1212/WNL.55.1.55 |
P698 | PubMed publication ID | 10891906 |
P2093 | author name string | Huang L | |
Cheuk W | |||
Goodkin DE | |||
Boudewyn AC | |||
Bacchetti P | |||
Mohr DC | |||
Dee B | |||
Marrietta P | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | psychological stress | Q3500368 |
P304 | page(s) | 55-61 | |
P577 | publication date | 2000-07-01 | |
P1433 | published in | Neurology | Q1161692 |
P1476 | title | Psychological stress and the subsequent appearance of new brain MRI lesions in MS. | |
P478 | volume | 55 |
Q48329480 | 2002 Robert Ader New Investigator award. Relationship of cardiovascular reactivity, stressful life events, and multiple sclerosis disease activity |
Q46875995 | A pilot, open label, clinical trial using hydroxyzine in multiple sclerosis |
Q36117334 | A randomized trial of stress management for the prevention of new brain lesions in MS |
Q36206179 | A review of stress-relapse interactions in multiple sclerosis: important features and stress-mediating and -moderating variables |
Q48294983 | Acute stress shortens the time to onset of experimental allergic encephalomyelitis in SJL/J mice |
Q41260693 | Antivirus immune activity in multiple sclerosis correlates with MRI activity. |
Q34307397 | Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis |
Q93271339 | Behavioral Interventions in Multiple Sclerosis |
Q38049624 | Behavioral interventions in multiple sclerosis: a biopsychosocial perspective. |
Q36946327 | Brain-immune communication psychoneuroimmunology of multiple sclerosis |
Q49972450 | Break-out session highlights |
Q34575351 | Can meditation influence quality of life, depression, and disease outcome in multiple sclerosis? Findings from a large international web-based study |
Q23909788 | Chronic illness in the workplace: stigma, identity threat and strain |
Q34220882 | Chronic immobilisation stress ameliorates clinical score and neuroinflammation in a MOG-induced EAE in Dark Agouti rats: mechanisms implicated. |
Q26782847 | Cognitive Reserve as a Useful Concept for Early Intervention Research in Multiple Sclerosis |
Q36822052 | Coping with neuroimmunological diseases |
Q48066589 | Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception. |
Q37258747 | Depression in multiple sclerosis: review and theoretical proposal |
Q36819882 | Differential release of mast cell mediators and the pathogenesis of inflammation |
Q34010780 | Do positive or negative stressful events predict the development of new brain lesions in people with multiple sclerosis? |
Q37991266 | End-point effector stress mediators in neuroimmune interactions: their role in immune system homeostasis and autoimmune pathology. |
Q34184766 | Evidence for CRHR1 in multiple sclerosis using supervised machine learning and meta-analysis in 12,566 individuals |
Q37217845 | Examining the evidence: complementary adjunctive therapies for multiple sclerosis |
Q34624054 | Gut microbiome and the risk factors in central nervous system autoimmunity. |
Q60440998 | How does stress affect you? An overview of stress, immunity, depression and disease |
Q41535957 | Immunogenic dendritic cells primed by social defeat enhance adaptive immunity to influenza A virus. |
Q89471144 | Impact of mindfulness-based stress reduction for people with multiple sclerosis at 8 weeks and 12 months: A randomized clinical trial |
Q48350687 | Increase in multiple sclerosis activity after assisted reproduction technology |
Q50778662 | Influence of anxiety and reported stressful life events on relapses in multiple sclerosis: a prospective study. |
Q42282484 | Interleukin-6 as a mechanism for the adverse effects of social stress on acute Theiler's virus infection. |
Q48277250 | Longitudinal evaluation of depression and anxiety in patients with clinically isolated syndrome at high risk of developing early multiple sclerosis |
Q39070531 | Managing psychological stress in the multiple sclerosis medical visit: Patient perspectives and unmet needs |
Q83029950 | Mast cells and inflammation |
Q35012299 | Mast cells: new targets for multiple sclerosis therapy? |
Q38238089 | Meditation as an adjunct to the management of multiple sclerosis |
Q37685038 | Metabolomic approach to human brain spectroscopy identifies associations between clinical features and the frontal lobe metabolome in multiple sclerosis. |
Q35844748 | Moderating effects of coping on the relationship between stress and the development of new brain lesions in multiple sclerosis |
Q33581753 | Modifiable factors influencing relapses and disability in multiple sclerosis. |
Q35521828 | Multiple sclerosis: diagnosis and the management of acute relapses |
Q34187515 | Multiple sclerosis: empirical literature for the clinical health psychologist |
Q50761855 | Negative affect predicts subsequent cognitive change in multiple sclerosis. |
Q33821451 | Neonatal maternal separation alters immune, endocrine, and behavioral responses to acute Theiler's virus infection in adult mice |
Q33563400 | Perceived stress in multiple sclerosis: the potential role of mindfulness in health and well-being. |
Q49110279 | Positive everyday experiences interact with social support to predict depression in multiple sclerosis |
Q44008838 | Postnatal maternal deprivation aggravates experimental autoimmune encephalomyelitis in adult Lewis rats: reversal by chronic imipramine treatment |
Q48712124 | Presentation and validation of the multiple sclerosis depression rating scale: a test specifically devised to investigate affective disorders in multiple sclerosis patients |
Q81002023 | Psychiatric manifestations of autoimmune disorders |
Q34775067 | Psychosocial stress predicts future symptom severities in children and adolescents with Tourette syndrome and/or obsessive-compulsive disorder |
Q34794107 | Quality of life in multiple sclerosis (MS) and role of fatigue, depression, anxiety, and stress: A bicenter study from north of Iran. |
Q34569849 | Relationship between stress and relapse in multiple sclerosis: Part I. Important features |
Q41463508 | Role of socioeconomic position in multiple sclerosis etiology. |
Q34542101 | Self reported stressful life events and exacerbations in multiple sclerosis: prospective study |
Q36862803 | Social conflict exacerbates an animal model of multiple sclerosis. |
Q35489039 | Social disruption induced priming of CNS inflammatory response to Theiler's virus is dependent upon stress induced IL-6 release |
Q46133925 | Social support as a buffer in the relationship between treatment for depression and T-cell production of interferon gamma in patients with multiple sclerosis |
Q33746339 | Streptococcal upper respiratory tract infections and psychosocial stress predict future tic and obsessive-compulsive symptom severity in children and adolescents with Tourette syndrome and obsessive-compulsive disorder |
Q43138128 | Stress and exacerbations in multiple sclerosis: whether stress triggers relapses remains a conundrum. |
Q36822089 | Stress and multiple sclerosis |
Q37540661 | Stress and multiple sclerosis: A systematic review considering potential moderating and mediating factors and methods of assessing stress |
Q38150625 | Stress in multiple sclerosis: review of new developments and future directions |
Q22241797 | Stress regulation in multiple sclerosis-current issues and concepts |
Q36163778 | The Goldman Consensus statement on depression in multiple sclerosis |
Q39002824 | The effect of executive function on stress, depression, anxiety, and quality of life in multiple sclerosis |
Q37360503 | The effects of stressful life events on the course of multiple sclerosis: a review |
Q30660682 | The neuropsychology of multiple sclerosis: contributions of neuroimaging research |
Q48162662 | Wellness and the Role of Comorbidities in Multiple Sclerosis. |
Q79783553 | [Mood and emotional disorders in Multiple Sclerosis: a literature review] |
Search more.